Jacksonville, Florida




Do you want to revolutionize health care? Do you want to conduct groundbreaking research in nanomedicine? If you answered yes to these questions, Dr. Wolfram's Nanomedicine and Extracellular Vesicles Laboratory is for you! Join a group of researchers who are passionate about thinking differently to solve major health care challenges.

Joy Wolfram, Ph.D., focuses her research in nanomedicine on the development of new strategies for the treatment of disease. In particular, her team is developing extracellular vesicle therapeutics and diagnostics. Dr. Wolfram aspires to generate fruitful interinstitutional research collaborations around the world.

Focus areas

  • Extracellular vesicle therapeutics
  • Extracellular vesicle diagnostics
  • Cancer
  • Cardiovascular disease
  • Drug delivery
  • Regenerative sciences

Significance to patient care

Dr. Wolfram's research goal is to bring new nanomedicine treatments to Mayo Clinic. Nanotechnology enables the design of multifunctional and targeted therapies, thereby increasing therapeutic efficacy and reducing side effects for patients.

Professional highlights

  • Rising Star in Cancer Research, The Scientist, 2020
  • Board member, Pharmatest, 2019-present
  • Associate Director, Regenerative Sciences Track, Mayo Clinic Graduate School of Biomedical Sciences, 2020-present
  • Co-leader, Regenerative Sciences Training Program, Mayo Clinic Graduate School of Biomedical Sciences, 2019-2020
  • Commissioner, Svenska Tekniska Vetenskapsakademien (Swedish Technical Science Academy), Finland, 2019-present
  • Director, Undergraduate Biomedical Research Internship Program, Mayo Clinic, Jacksonville, Florida, 2019-present
  • Member, Global Young Academy, 2019-present
  • Working group member, Biomedical Sciences Program, University of North Florida, 2019-present
  • Board member, Group Dash Ltd., 2018-present
  • Chair, Physical Sciences-Oncology Network Education and Outreach Working Group, National Cancer Institute, 2018-present
  • Editorial board member, Scientific Reports, 2018-present
  • Scientific advisory board member, Genomill Health, 2018-present
  • Associate research professor, Wenzhou Institute of Biomaterials & Engineering, Ningbo Institute of Industrial Technology, China, 2017-2019
  • Affiliate assistant faculty member, Department of Nanomedicine, Houston Methodist Research Institute, 2017-present
  • Board member, Bidwater, 2017-present
  • Courtesy research faculty member, Department of Biology, University of North Florida, 2017-present
  • Working group representative, Education and Outreach Unit, Center for Immunotherapeutic Transport Oncophysics of the National Cancer Institute, Houston Methodist Research Institute, 2016-present
  • Board member and co-owner, Oy Wolfram Ab, 2013-present
  • Chair, RNA Nanotechnology Gordon Research Seminar, 2019
  • Named, Forbes 30 Under 30, U.S. & Canada, 2019
  • Shortlisted, Nature Research Award for Inspiring Science, 2019
  • Speaker, "How Nanoparticles Could Change the Way We Treat Cancer," TED, 2019
  • Internationally Accomplished Finn, Inspired in Finland, 2017
  • Named, Amgen Scholars Ten to Watch List, Amgen Foundation, 2016


See my publications


Administrative Appointment

  1. Associate Consultant I-Research, Department of Physiology and Biomedical Engineering
  2. Associate Consultant I-Research, Department of Biochemistry and Molecular Biology
  3. Associate Consultant I-Research, Department of Transplantation

Academic Rank

  1. Assistant Professor of Medicine


  1. PhD - In collaboration with the Houston Methodist Hospital, Houston, Texas, United States University of Chinese Academy of Sciences
  2. MS University of Helsinki
  3. BS University of Helsinki

Mayo Clinic Footer